Preclinical News and Research

RSS
Mediso launches MultiScan LFER 150 PET/CT for research applications

Mediso launches MultiScan LFER 150 PET/CT for research applications

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

Researchers define the process of Parkinson's disease using genetic mouse model

Researchers define the process of Parkinson's disease using genetic mouse model

Researchers develop DNA-based drug delivery system that targets cancer cells

Researchers develop DNA-based drug delivery system that targets cancer cells

Four UCLA researchers receive NIH Director's New Innovator Award

Four UCLA researchers receive NIH Director's New Innovator Award

Isis Pharmaceuticals provides update on Phase 2 clinical studies of ISIS-SMN Rx in children with SMA

Isis Pharmaceuticals provides update on Phase 2 clinical studies of ISIS-SMN Rx in children with SMA

First study of promising Ebola vaccine commenced in West Africa

First study of promising Ebola vaccine commenced in West Africa

Specific perceptual learning deficit associated with Fragile X Syndrome

Specific perceptual learning deficit associated with Fragile X Syndrome

New drug discovery tool against Ebola virus

New drug discovery tool against Ebola virus

Absorption Systems supports Pediatric Praziquantel Consortium led by Merck KGaA

Absorption Systems supports Pediatric Praziquantel Consortium led by Merck KGaA

ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

NKT Therapeutics' NKTT120 receives FDA Fast Track designation for treatment of sickle cell disease

NKT Therapeutics' NKTT120 receives FDA Fast Track designation for treatment of sickle cell disease

Ganymed, BioNTech AG open new headquarters and research facility in Germany

Ganymed, BioNTech AG open new headquarters and research facility in Germany

Allakos secures additional $10M investment to expand its development portfolio

Allakos secures additional $10M investment to expand its development portfolio

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

VCU receives $6 million grant to develop safe, effective treatments for cocaine addiction

VCU receives $6 million grant to develop safe, effective treatments for cocaine addiction

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Combination therapy achieves greater progression-free survival, response rates in melanoma

Combination therapy achieves greater progression-free survival, response rates in melanoma

Arisaph Pharmaceuticals receives STTR grants to develop cancer drug candidates

Arisaph Pharmaceuticals receives STTR grants to develop cancer drug candidates

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.